Overall, 31.2% of U.S. physicians say they have been sued. When looking at only cardiologists, the percentage is slightly higher.

The move is expected to wipe out the entire investment of KKR, which first took the publicly traded physician group private in a 2018 $5.5B buyout. 

FFR-CT has grown in popularity due its ability to provide noninvasive evaluations of patients being considered for revascularization procedures. According to a new study in JACC: Cardiovascular Imaging, however, stress imaging strategies may still provide more value in certain scenarios. 

The mid-market-sized Growth Fund has hired advisors and is now gauging interest from potential buyers, according to a recently published report. 

PET/CT saw the biggest gains, up almost 21% year-over-year compared to Q1 of 2022, with the group collecting $390M in revenue (up 14%). 

Although the vaccine maker previously cut expenses by $50 million without laying off staff, the measures were not enough to keep pace with the effects of the COVID-19 global health emergency. 

The company reported a Q1 revenue of $161.1 million, up 72% from Q1 in 2022. Both gross profit and net income were also up considerably when compared to 2022. 

Talks between the two companies have reached a standstill, according to a new report. The rumor appears to have impacted the stock prices of both Boston Scientific and Shockwave Medical.